Amlodipine Besylate Prices

Amlodipine Besylate Prices June 2024

The amlodipine besylate prices in the United States for Q2 2024 reached 72000 USD/MT in June. The USA witnessed volatile pricing due to a strong early demand and subsequent economic uncertainty. The prices for amlodipine besylate hiked in April and May, driven by increased shipping challenges and consumer spending but fell in June amid weakened business sentiment and reduced demand in the healthcare sector, closing the quarter in a subdued pricing environment.

The price trend for amlodipine besylate in China for Q2 2024 settled at 71010 USD/MT in June. The market faced fluctuating prices, initially rising due to strong international and domestic demand. Increased production met this surge but reduced raw material costs and oversupply by quarter’s end led to a decline in prices, which resulted in subdued external demand.

In Germany, the amlodipine besylate prices for Q2 2024 reached 70000 USD/MT in June. The market initially witnessed prices rise with the strong consumer demand and rising supply chain costs. During the end of the quarter, prices declined because of excess stock, lower freight rates, and subdued demand linked to warmer weather. Economic pressures and stable interest rates continued to limit purchasing activity, resulting in an overall price drop.

Amlodipine Besylate Prices December 2023

The amlodipine besylate prices in the United States for Q4 2023 reached 75,190 USD/MT in December. The market witnessed price fluctuations influenced by economic pressures such as high interest rates and inflation. These factors led to a downturn in consumer confidence, impacting demand and pricing within the market.

The price trend for amlodipine besylate in China for Q4 2023 reached 73,845 USD/MT in December. The market saw price adjustments due to a revival in domestic demand in November, despite ongoing challenges from sluggish international demand. This resulted in fluctuating prices as the market responded to shifting demand dynamics.

In Germany amlodipine besylate prices reached 74,672 USD/MT in December. The market was characterized by weakened demand, primarily due to rising inflation and the resulting strain on consumer budgets. These economic conditions influenced pricing trends and overall market activity in the region.

Regional Coverage

The report provides a detailed analysis of the amlodipine besylate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the amlodipine besylate price trend.

Global Amlodipine Besylate Price

The report offers a holistic view of the global amlodipine besylate pricing trends in the form of amlodipine besylate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights the current price but also provides insights into amlodipine besylate historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into amlodipine besylate price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed amlodipine besylate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Amlodipine Besylate Price

Q2 2024:

During the second quarter of 2024, the European market experienced varied pricing trends shaped by shifting economic conditions and market dynamics. Early in the quarter, prices increased due to a surge in consumer spending and heightened demand for Amlodipine besylate, coupled with increased supply chain costs from rising energy prices and labor expenses. However, by the end of the quarter, prices started to drop as the demand waned amidst an overstocked market. A slowing economy and fewer illness cases due to warmer weather also contributed to a demand slump, while stable interest rates imposed additional economic strain on consumers.

Q1 2024:

During the first quarter of 2024, the European market exhibited fluctuating pricing trends shaped by diverse economic and market conditions. Initially, prices eased due to softer consumer sentiment as well as economic concerns, with reduced needs from the healthcare and pharmaceutical industries contributing to the decrease. Midway through the quarter, however, prices increased in response to a combination of increasing consumer needs, inventory constraints, and logistical challenges. These disruptions, partly stemming from the Spring Festival across China, impacted shipping schedules and elevated transport costs, which, in turn, pushed up prices across the market. In March, prices witnessed another notable drop due to sluggish local demand and a high backlog of industrial orders, weighing heavily on market confidence.

Q4 2023:

The European market for amlodipine besylate witnessed a drop in demand in Q4 2023, primarily in Germany, as a result of elevated inflation. The European Central Bank's decision to raise interest rates further reduced consumer demand. Additionally, the market was characterized by an oversupply, leading manufacturers to lower prices to reduce their inventory levels. Overall, the European market faced a downturn in demand compounded by economic factors such as inflation and interest rates, affecting pricing strategies and market stability.

This analysis can be extended to include detailed amlodipine besylate price information for a comprehensive list of countries.

North America Amlodipine Besylate Price

Q2 2024:

During the second quarter of 2024, the amlodipine besylate market in North America experienced a trend driven by a combination of supply-demand dynamics, inventory shifts, and broader trade movements. In the USA, fluctuations were particularly notable, with prices rising through April and May before witnessing a downturn in June. Initially, the surge was propelled by strong domestic demand and robust retail activity, as well as logistical challenges stemming from longer shipping routes in the Red Sea, which pushed fuel and charter costs further. The quarter closed with subdued market activity, reflecting the complex economic landscape and evolving demand factors.

Q1 2024:

In the first quarter of 2024, the amlodipine besylate market in North America, especially in the United States, experienced shifting pricing trends due to varied market forces. Initially, prices reduced slightly as the demand from downstream sectors weakened, accompanied by an ample supply. Inflationary effects and the Federal Reserve’s steady interest rate policy contributed to restrained spending, amplifying the downward pressure.  Maritime route disruptions further impacted imports. However, a drop in business confidence by March curbed the demand in the healthcare and pharmaceutical sectors, causing prices to fall. Year-over-year, the first quarter of 2024 prices ended below the prior year, highlighting an overall decline.

Q4 2023:

Throughout Q4 2023, the North American amlodipine besylate market was primarily shaped by inflationary pressures and elevated interest rates. This economic environment contributed to a reduction in consumer spending and a subdued demand for amlodipine besylate, leading to fluctuating prices throughout the region. In the United States, the market showed a mild recovery by November, prompted by a slight ease in inflation which boosted consumer confidence and spending. Overall, the market in this region encountered challenges related to consumer confidence and economic conditions, influencing the pricing trends of amlodipine besylate.

Specific amlodipine besylate historical data within the United States and Canada can also be provided.

Middle East and Africa Amlodipine Besylate Price

The report explores the amlodipine besylate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on amlodipine besylate prices for countries can also be provided.

Asia Pacific Amlodipine Besylate Price

Q2 2024:

During the second quarter of 2024, the Asia Pacific market displayed varied pricing trends of amlodipine besylate shaped by a range of economic and market factors. Early in the quarter, market confidence soared, pushing prices higher as both international and domestic demand surged, prompting manufacturers to boost manufacturing levels significantly. This increase in manufacturing accelerated growth, driven by a strong inflow of orders. In line with this, contributing to the price dip were lower manufacturing costs, which stemmed from a decline in transportation and raw material expenses, allowing suppliers to alter prices accordingly. Additionally, export demand stayed tepid due to high interest rates in key global markets, impacting consumer purchasing power.

Q1 2024:

During the first quarter of 2024, the amlodipine besylate market across the Asia Pacific, especially across China, exhibited nuanced shifts driven by a mix of factors such as worldwide economic shifts, supply chain dynamics, and domestic production. Initially, prices saw a mild decrease as weakened downstream demand weighed on the market. China’s production sector encountered challenges, with restrained external demand and sluggish domestic recovery. Mid-quarter, prices rose sharply because of limited inventories as the Spring Festival sought to reduce output or factory closures, creating a temporary shortage and intensifying competition among buyers. By the end of the quarter, despite improved economy-related activities post-holiday, prices again softened due to lackluster domestic demand.

Q4 2023:

The market in the Asia Pacific region during Q4 2023 was marked by stability in supply but weak demand due to sluggish global and domestic orders. In China, the manufacturing industry saw a recovery in November, although it continued to face challenges from a lack of overseas enquiries. Due to this, prices varied during the quarter. There was a noticeable decrease in October, which was followed by a recovery in November as end-user industry demand began to stabilize, and then another reduction in December as a result of decreased trade activity. This pattern reflects the broader market dynamics of steady supply and varied demand across the region.

This amlodipine besylate price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Amlodipine Besylate Price

The analysis of amlodipine besylate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Amlodipine Besylate Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Amlodipine Besylate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of amlodipine besylate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of amlodipine besylate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of amlodipine besylate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing amlodipine besylate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Amlodipine Besylate Market Analysis

The global amlodipine besylate market size reached US$ 389.6 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 622.2 Million, at a projected CAGR of 5.30% during 2023-2032.

• The increasing prevalence of hypertension cases represents one of the key factors influencing the growth of the market across the globe. This is primarily attributed to the lifestyle changes, dietary factors, and aging population which are driving the market growth. According to the Centers for Disease Control and Prevention, in 2021, hypertension was a primary or contributing cause of 6,91,095 deaths in the United States. About one in four adults with hypertension have their hypertension under control (22.5%, 27.0 million). This is further supporting the demand for amlodipine besylate.
• The rising demand for managing high blood pressure is fueling the demand for amlodipine besylate as a primary medication. According to the Centers for Disease Control and Prevention, a greater percentage of men (50%) have high blood pressure than women (44%). High blood pressure is more common non-Hispanic black adults (56%) than in non-Hispanic white adults (48%), non-Hispanic Asian adults (46%), or Hispanic adults (39%).
• The market is also driven by the affordability of amlodipine besylate as compared to other hypertension medications. Moreover, the expiration of patents for branded versions of amlodipine besylate is leading to the emergence of generic drugs, which are cheaper and hence driving a broader market reach. According to IMS Health Institute, generic drugs saved the US healthcare system nearly $2.2 trillion from 2009 to 2019.
• The increasing awareness about hypertension and its risk, along with improved healthcare infrastructure, and more individuals seeking treatment are facilitating the growth of the market. According to World Health Organization (WHO), an estimated 1.28 billion adults aged 30 to 79 years across the globe have hypertension, most (two-third) living in low- and middle-income countries. An estimated 46% of adults with hypertension are unaware that they have the condition. Less than half of adults (42%) with hypertension are diagnosed and treated. Approximately, 1 in five adults (21%) with hypertension have it under control.

Amlodipine Besylate News

The report covers the latest developments, updates, and trends impacting the global amlodipine besylate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in amlodipine besylate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the amlodipine besylate price trend.

Latest developments in the amlodipine besylate industry:

• In February 2024, Dr. Reddy’s Laboratories announced that they received a Voluntary Action Indicated (VAI) status from the United States Food and Drug Administration (USFDA) following an inspection of its research and development (R&D) centres for Integrated Product Development Organisation (IPDO) in Bachupally, Hyderabad.
• In January 2024, Teva announced its intention to divest its active pharmaceutical ingredient (API) business, or “TAPI”. TAPI is a global leader in the small molecule API industry, with approximately 4,300 employees worldwide.

Product Description

Amlodipine besylate refers to a prescription medication excessively utilized in the management of high blood pressure (hypertension) and certain types of chest pain such as angina.

Amlodipine besylate belongs to the class of drugs known as calcium channel blockers. It works by relaxing and widening blood vessels, which improves blood flow and makes it easier for the heart to pump blood. This mechanism not only aids in reducing blood pressure level but also prevents heart attacks, strokes, and kidney problems.

Amlodipine besylate is also administered orally, and its dosages vary based on the condition being treated, patient response, and other medications being taken. While it is generally well tolerated, potential side effects such as swelling, fatigue, and dizziness. Patients are advised to consult their healthcare provider before starting or making any changes to their medication regimen to ensure it's safe and effective for their specific health conditions.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of amlodipine besylate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting amlodipine besylate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The amlodipine besylate price charts ensure our clients remain at the forefront of the industry.